Study to evaluate the performance of the AggreGuide A-100 ADP assay for detection of platelet dysfunction caused by P2Y12 inhibitor antiplatelet therapy. Study subjects will have measurements performed at baseline and after initiation of P2Y12 inhibitor antiplatelet therapy.